Organic compounds -- part of the class 532-570 series inventions 07/07

20070173642 - Process for the purification of macrolides: Process for the recovery of a macrolide in substantially pure form comprising: a) treatment of an impure or crude macrolide with water immiscible solvent, b) optional concentration of the mixture, c) treatment with ammonia gas to phase out impurities, d) separation of impurities, d) optional concentration of the phase containing... Agent: Caesar, Rivise, Bernstein, Cohen & Pokotilow, Ltd.

20070167617 - Method of making a diisocyanate terminated macromer: A method for making a polyisocyanate macromer is described herein.... Agent: Philip S. Johnson Johnson & Johnson

20070167618 - Manufacture of cellulose esters: recycle of caustic and/or acid from pre-treatment of pulp: A process for the manufacture of cellulose esters is described. The process includes the steps of: pre-treating pulp for the removal of impurities with either caustic or acid or both, esterifying the pre-treated pulp, and recycling the caustic or acid or both from the pre-treating step.... Agent: Hammer & Hanf, PC

20070161787 - C-glycoside derivatives and salts thereof: The present invention provides C-glycoside derivatives and salts thereof, wherein B ring is bonded to A ring via —X— and A ring is directly bonded to the glucose residue, and it is usable as a Na+-glucose cotransporter inhibitor, especially for a therapeutic and/or preventive agent for diabetes such as insulin-dependent... Agent: Sughrue Mion, PLLC

20070161788 - Selected nucleotide sequences isolated from pathogenic strains of haemophilus influenzae: A DNA sequence of Haemophilus influenzae clone 151_04 shown in SEQ. ID. NO. 1. A DNA sequence of Haemophilus influenzae clone 125_L2 shown in SEQ. ID. NO. 2. A DNA sequence of Haemophilus influenzae clone 179_D14 shown in SEQ. ID. NO. 3. A DNA sequence of Haemophilus influenzae clone 167_A16... Agent: Ansel M. Schwartz Suite 304